Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report
Yuqiang Zhou, Zhiliang Zhang, Shasha Liu, Jiang Nan, Zhuoli Zhang, Zixian Chen · 2026
Read Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report by Yuqiang Zhou, Zhiliang Zhang, Shasha Liu, Jiang Nan, Zhuoli Zhang, Zixian Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272056.txt.
Description
Yuqiang Zhou and coauthors report in 2026 a case of heart muscle inflammation triggered by a cancer immunotherapy drug in a man with liver cancer. Drugs that release immune brakes can rarely inflame the heart, a side effect with high fatality. Prompt recognition is therefore critical when chest symptoms follow treatment.
The 56-year-old patient developed myocarditis after two cycles of the PD-1 blocker sintilimab. Heart imaging suggested the diagnosis, and a small heart tissue sample confirmed it. High-dose steroids plus supportive care brought marked improvement. The case adds to guidance on watching the heart during immune therapy for liver cancer.
Catalog record
| CREATOR | Yuqiang Zhou, Zhiliang Zhang, Shasha Liu, Jiang Nan, Zhuoli Zhang, Zixian Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |